# Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery

> **NCT02184273** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 122 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Magnesium metamizol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02184273
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2004-03
- **Final completion:** —
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2014-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184273, "Efficacy and Tolerability of Nolotil i.v. vs. Placebo i.v. in the Prevention of Postoperative Pain in Children Undergoing Minor Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02184273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*